SIGNIFICATION OF MAGNESIUM IN THERAPY OF CARDIOVASCULAR DISEASES

B. Vučinić ,
B. Vučinić

Health centre Kosovska Mitrovica Kosovo*

R. Mitić ,
R. Mitić

Institute of Pharmacology and toxicologhy, Faculty of Medicine, University of Priština - Kosovska Mitrovica , Mitrovica , Kosovo

Z. Milovanović
Z. Milovanović

Institute of Physiology, Faculty of Medicine, University of Priština - Kosovska Mitrovica , Mitrovica , Kosovo

Published: 01.12.2006.

Volume 34, Issue 2 (2006)

pp. 93-106;

https://doi.org/10.70949/pramed200602163V

Abstract

Cardiovascular diseases are one of the most significant social-medical problems. Having on mind their importance, the risk factors have been defined. Numerous clinical and epidemiological studies showed that deficit of magnesium in the human organism has a certain contribution in etiology, pathogenesis and evolution of cardiovascular diseases. RASKO, Rakovica's study of cardiovascular diseases, found out that these diseases are more frequent at the locations where
soft water with decreased content of magnesium is being used as drinking water. Magnesium is an integral part of about 300 enzyme systems in which catalyst's role have adenositriphospathase as Mg-ATP, a part of NaKATP-ase, exogenous and endogenous pumps for calcium, etc. A normal plasmatic concentration of magnesium is 0,8-1 mmol/l. Plasmatic level of magnesium is not directly correlated with actually content in an organism since 33% of plasmatic magnesium is connected with plasma's proteins and that's why hypoproteinemia can cause a false hypomagnesemia. The normal values of magnesemia don't exclude deficit of magnesium in an organism since PTH and calcitonin mobilize magnesium from the bones. Hypomegnesemia is caused by improper and irrational nutrition, hormone disturbances, and different conditions and diseases of an organism. Magnesium has vasodiletatoric, antianginosic, hypolipemic, antiagregatic effects. Mechanism of magnesium's effect is based on its physiological role in an organism, i.e. on correction of hypomagnesemia. In preventive and therapeutic purposes magnesium's compounds are used peroraly and parenteraly. With parenteral use the plasmatic concentrations of more than physiological 2,5-7,5 mEq/l can be attained in which case somnolentia can be appeared but not a coma nor depression of breathing. In prevention and therapy of cardiovascular diseases magnesium has a significant place in the largest number of cases as an adjuvant drug

Keywords

References

1.
Nikolić B. Biohemija.
2.
Karlson. Biokemija. Sveučilište u Zagrebu.
3.
Mitić R. Praktikum iz medicinske recepture.
4.
Mitić R, Tomić Z. Interakcije lekova i uticaj lekova na laboratorijske analize. Medicinski fakultet Priština.
5.
Mujović VM. Faktori rizika i homeostaza.
6.
Mujović VM. Homeostaza i telesne tečnosti.
7.
Kardiologija NS. Zavod za izdavanje udžbenika.
8.
Nedeljković IS, Kanjuh V, Kardiologija VM. Medicinski fakultet.
9.
Nedeljković IS, Kanjuh V, Vukotić M. Vaše srce i krvni sudovi.
10.
Jakulić S. Biološke osnove psihijatrije. Zavod za izdavanje udžbenika.
11.
Facts and Comparisons.
12.
Remington’s Pharmaceutical Sciences.
13.
Pavlović D. Epidemiologija, higijena i socijalna medicina. In: Zavod za izdavanje udžbenika Priština.
14.
Lj P. Preporučeni dnevni unos namirnica.
15.
Novi Svet RDF, Priština.
16.
Shirkey HC. Pediatric Dosage Handbook.
17.
Stefanović S. Interna medicina. Zavod za udžbenike i nastavna sredstva, Medicinska knjiga.
18.
Dyckner T, Wester PO, Widman L. Effects of peroral magnesium on plasma and skeletal muscle electrolytes in patients on long-term diuretic therapy. Intern J Card. 19:81–7.
19.
Abraham AS, Rosenman D, Kramer M. Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction. Arch Intern Med. 147:753–5.
20.
Anderson RJ, Gambertoglio JG, Schrier RW. Clinical Use of Drugs in Renal Failure.
21.
Brovne SE. Magnesium sulphate in arterial disease. Perticone i sar. 228:1165–6.
22.
Cappuccio FP, Markandu ND, Beeeynon GW. Lack of effects of oral magnesium on high blood pressure: a double blind study. Br Med J. 291:235–8.
23.
Chruinshank DP, Varner MW, Pitkin RM. Breast milk magnesium and calcium concentrations following magnesium sulphate treatment. Am J Obstet Gynecol. 143:685–8.
24.
Cohen L, Kitzes R. Magnesium sulfate and digitalis-toxic arrhythmias. JAMA. 249:2808–10.
25.
Dyckner T, Wester PO. Effect of magnesium on blood pressure. Br Med J. 286:1847–9.
26.
Dyckner T, Wester PO. Effects of magnesium infusions in diuretic-induced hyponatraemia. Lancet. 1(585).
27.
hemija ASN. Naučna knjiga.
28.
Dukes MNG. Meyler’s Side Effects of Drugs.
29.
Fuentes A, Goldkrand JW. Angiotensin-converting enzyme activity in hypertensive subjects after magnesium sulfate therapy. Am J Obstet Gynecol. 156:1375–9.
30.
31.
Gilman AG, Goodman LS. Gilman A.
32.
Harrison TR. Principles of Internal Medicine.
33.
Havel RJ, Calloway DH, Gussow JD. Recommended Dietary Allowances.
34.
Henderson DG, Schierup J, Schodt T. Effects of magnesium supplementation on blood pressure and electrolyte concentrations in hypertensive patients receiving long-term diuretic treatment. Br Med J. 293:664–5.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by